PSMA-targeted arsenic nanosheets: a platform for prostate cancer therapy via ferroptosis and ATM deficiency-triggered chemosensitization.

Wang, Hui; Zhang, Li; Miao, Zhaohua; Zhang, Meng; Liu, Hang; He, Qiong; Meng, Jialin; Wen, Longping; Ke, Zunfu; Zha, Zhengbao; Lin, Run; Liang, Chaozhao

Wang, Hui; Zhang, Li; Miao, Zhaohua; Zhang, Meng; Liu, Hang; He, Qiong; Meng, Jialin; Wen, Longping; Ke, Zunfu; Zha, Zhengbao; Lin, Run; Liang, Chaozhao.

Affiliation

Wang H; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Institute of Urology, Anhui Medical University and Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, 230022, China. liang_chaozhao@ahmu.edu.cn.

Mater Horiz ; 8(8): 2216-2229, 2021 08 01.

Article in En | MEDLINE | ID: mdl-34846426

Subject(s)

Arsenic; Ataxia Telangiectasia; Ferroptosis; Prostatic Neoplasms; Arsenic/metabolism; Ataxia Telangiectasia Mutated Proteins/genetics; Glutathione/metabolism; Humans; Male; Prostatic Neoplasms/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arsenic / Prostatic Neoplasms / Ataxia Telangiectasia / Ferroptosis Limits: Humans / Male Language: En Journal: Mater Horiz Year: 2021 Document type: Article Affiliation country: China Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google